Tuesday, July 1, 2025 7/1/2025

Global identification of novel protease activity for Coccidioides, the Valley fever pathogen

Award Number: R21AI140020
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 06/22/2018
PERIOD OF PERFORMANCE END DATE: 05/31/2023

Group Awards By:

View Award Description

Global identification of novel protease activity for Coccidioides, the Valley fever pathogen - Project Summary/Abstract Coccidioides immitis and Coccidioides posadasii are the fungal species responsible for the disease termed coccidioidomycosis or Valley fever, which is designated as an orphan disease by the FDA. Coccidioides species are endemic in the soil throughout California, Arizona, Mexico, and Central and South America. On average, Valley fever infects an estimated 150,000 individuals per year in the United States, with cases steadily rising as climate temperatures increase in endemic areas. There is no definitive diagnostic available for Valley fever. Currently, patients are diagnosed by chest x- rays that rely heavily on the experience of clinicians, sputum culture microbiological examination/enumeration, and blood sample tests for antibodies. These diagnostic methods suffer from low sensitivity and slow turnaround times (days to often weeks), and are typically made after the patient has displayed severe symptoms of infection. Therefore, an urgent need exists to develop a rapid and non-invasive method for detecting Coccidioides. In addition, this diagnostic should be sufficiently sensitive to enable early detection of the pathogen, prior to the onset of severe or life-threatening symptoms. The overall objective of this R21 proposal is to begin the exploratory pathway for a rapid, sensitive, and non-invasive method for detecting Coccidioides that would significantly change current clinical practice by enabling the early identification of Valley fever, before it has had the chance to become life-threatening. Our proposal focuses on using Coccidioides-specific proteases as a target for development of a diagnostic. To do this, in Aim 1, we use a technology called multiplex substrate profiling by mass spectrometry (MSP-MS) to detect proteolytic activity in cell-free secretions from C. immitis and C. posadasii and use this information to develop protease-cleavable fluorogenic substrates. MSP-MS allows for unbiased and simultaneous detection of all protease activities in a given sample; it employs a library of rationally designed peptide substrates and monitors their cleavage. In Aim 2 we evaluate our fluorogenic substrates in preclinical mouse models of coccidioidomycosis to provide feasibility for downstream human sample testing. If successful, this R21 will set the framework for the development of a substrate-based diagnostic for the detection of Coccidioides in Valley fever patients.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = -$107 )
2024	2019	UNIVERSITY OF CALIFORNIA, MERCED	5200 N LAKE RD	MERCED	CA	95343	MERCED	USA	Allergy and Infectious Diseases Research	000	2	3/20/2024	NON-COMPETING CONTINUATION	-$107
														Subtotal = -$107

Issue Date FY: 2022 ( Subtotal = $0 )
2022	2019	UNIVERSITY OF CALIFORNIA, MERCED	5200 N LAKE RD	MERCED	CA	95344	MERCED	USA	Allergy and Infectious Diseases Research	000	2	5/13/2022	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2021 ( Subtotal = $0 )
2021	2019	UNIVERSITY OF CALIFORNIA, MERCED	5200 N LAKE RD	MERCED	CA	95344	MERCED	USA	Allergy and Infectious Diseases Research	000	2	5/12/2021	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2019 ( Subtotal = $232,500 )
2019	2019	UNIVERSITY OF CALIFORNIA, MERCED	5200 N LAKE RD	MERCED	CA	95344	MERCED	USA	Allergy and Infectious Diseases Research	000	2	5/23/2019	NON-COMPETING CONTINUATION	$232,500
														Subtotal = $232,500

Issue Date FY: 2018 ( Subtotal = $207,500 )
2018	2018	UNIVERSITY OF CALIFORNIA, MERCED	5200 N LAKE RD	MERCED	CA	95344	MERCED	USA	Allergy and Infectious Diseases Research	000	1	6/21/2018	NEW	$207,500
														Subtotal = $207,500

Grand Total All Awards = $439,893

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Global identification of novel protease activity for Coccidioides, the Valley fever pathogen

Award Number: R21AI140020

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 06/22/2018

PERIOD OF PERFORMANCE END DATE: 05/31/2023

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer